Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 1 or 2 Diabetes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT06547541
What this trial is testing

Pilot - Resistance Exercise for Inpatient Treatment in T2D

Who this might be right for
Diabetes Mellitus, Type 2Prediabetes or DiabetesPrediabetes
Rigshospitalet, Denmark 4
Not applicableStudy completedNCT01454024
What this trial is testing

Evaluating Safety of NovoPen® 3 and/or FlexPen® Devices in Routine Clinical Practice

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2+1 more
Novo Nordisk A/S 1,031
Not applicableStudy completedNCT03674866
What this trial is testing

A Canadian Study of the Effectiveness of Tresiba® (Insulin Degludec) After Switching Basal Insulin in a Population With Type 1 or Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 662
Large-scale testing (Phase 3)Study completedNCT01709929
What this trial is testing

Safety of Insulin Detemir for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes Mellitus

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 2,287
Large-scale testing (Phase 3)Study completedNCT00872560
What this trial is testing

Comparison of 2 NovoFine® Needles on the Reflux of Insulin

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Delivery Systems
Novo Nordisk A/S 60
Not applicableStudy completedNCT01548248
What this trial is testing

Efficacy and Safety of Levemir® Used as Basal Insulin

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 631
Testing effectiveness (Phase 2)Study completedNCT04265261
What this trial is testing

Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Hoffmann-La Roche 139
Not applicableEnded earlyNCT01201928
What this trial is testing

Pulmonary Function Substudy for Subjects Enrolled in Studies MKC-TI-161, MKC-TI-162 or MKC-TI-166

Who this might be right for
Type 1 Diabetes MellitusType 2 Diabetes Mellitus
Mannkind Corporation 3
Not applicableStudy completedNCT02105103
What this trial is testing

European, Open-label, Prospective, Multinational, Multicenter Study in Adult Subjects With Type 1 or Type 2 Diabetes Previously on MDI or CSII Therapy. Subjects Home Setting is Considered Routine Practice.

Who this might be right for
Type 2 Diabetes, Type 1 Diabetes
Hoffmann-La Roche 80
Large-scale testing (Phase 3)Study completedNCT00617565
What this trial is testing

Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 219
Not applicableLooking for participantsNCT07212075
What this trial is testing

Precision Subclassification of Mental Health in Diabetes: Digital Twins for Precision Mental Health to Track Subgroups

Who this might be right for
Diabetes (DM)Diabete MellitusDiabete Type 1+17 more
Forschungsinstitut der Diabetes Akademie Mergentheim 1,809
Not applicableStudy completedNCT00698269
What this trial is testing

An Observational Study of Efficacy and Safety of Modern Insulin in Diabetes Patients Switched From Anti-diabetic Treatment

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 5,926
Large-scale testing (Phase 3)Ended earlyNCT04606576
What this trial is testing

Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Oramed, Ltd. 710
Large-scale testing (Phase 3)Study completedNCT00604383
What this trial is testing

Protein Kinase C (PKC) Inhibitor-Diabetic Retinopathy Phase 3 Study

Who this might be right for
Diabetic Retinopathy
Chromaderm, Inc. 685
Testing effectiveness (Phase 2)Ended earlyNCT01069965
What this trial is testing

Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
N-Gene Research Laboratories, Inc. 196
Not applicableStudy completedNCT01941290
What this trial is testing

BIOFLOW III Asia Registry Orsiro Stent System

Who this might be right for
Coronary Artery DiseaseMyocardial IschemiaDiabetes Mellitus Type 1 or 2
BIOTRONIK Asia Pacific Pte Ltd 387
Not applicableStudy completedNCT01542489
What this trial is testing

Observational Study of the Predictability of Levemir® in Terms of Metabolic Control, Change of Body Weight and Hypos

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 480
Large-scale testing (Phase 3)Study completedNCT02585778
What this trial is testing

Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin)

Who this might be right for
Hypercholesterolaemia
Sanofi 517
Not applicableStudy completedNCT00671008
What this trial is testing

Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 400
Not applicableStudy completedNCT01460446
What this trial is testing

ACCU-CHEK® Aviva Expert Study: Does Use of a Bolus Advisor Improve Glycemic Control in Patients Not Achieving Optimal Control Using Multiple Daily Injections (MDI)?

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Hoffmann-La Roche 218
Next Page